Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Sandra Piqueras Ruiz"'
Autor:
Crhistian-Mario Oblitas, Francisco Galeano-Valle, Carmen Cuenca-Carvajal, Sandra Piqueras-Ruiz, Rubén Alonso-Beato, Álvaro Alejandre-de-Oña, Paula Carrascosa-Fernández, Agustín-Diego Chacón Moreno, Alejandro Parra-Virto, María-Teresa Pérez Sanz, Laura Abarca Casas, Clara Millán-Nohales, Luis Álvarez-Sala-Walther, Pablo Demelo-Rodríguez
Publikováno v:
Infectious diseases (London, England). 54(12)
The real predictive prognostic capacity of cellular indices (or ratios) is unclear in SARS-CoV-2 infection. This study aimed to assess the prognostic role of previously well-known laboratory indices and new ones in hospitalized COVID-19 patients.A re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d561dd2da278aee8be1fa5530221e97
https://pubmed.ncbi.nlm.nih.gov/36221980
https://pubmed.ncbi.nlm.nih.gov/36221980
Autor:
Ana Torres do Rego, Alejandro Parra Virto, Sandra Piqueras Ruiz, Pablo Demelo Rodríguez, Luis Antonio Alvarez-Sala Walther
Publikováno v:
Clínica e Investigación en Arteriosclerosis. 32:30-32
Inhibitors of the protein PCSK9, available since 2015, are capable of reducing the concentration of low density lipoprotein cholesterol by 40 to 70%, thus reducing the cardiovascular risk. The present case reports an adverse cardiovascular event that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0634eadb3dc98528bd3f0de7f5f822f2
https://doi.org/10.1016/j.arteri.2019.04.003
https://doi.org/10.1016/j.arteri.2019.04.003
Autor:
Alejandro Parra Virto, Luis Antonio Alvarez-Sala Walther, Sandra Piqueras Ruiz, Pablo Demelo Rodríguez, Ana Torres do Rego
Publikováno v:
Clínica e Investigación en Arteriosclerosis (English Edition). 32:29-31
Inhibitors of the protein PCSK9, available since 2015, are capable of reducing the concentration of low density lipoprotein cholesterol by 40–70%, thus reducing the cardiovascular risk. The present case reports an adverse cardiovascular event that
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fc8a792c90b38745dbfa382e016bba8
https://doi.org/10.1016/j.artere.2019.04.002
https://doi.org/10.1016/j.artere.2019.04.002
Publikováno v:
Blood research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97fa9ea69bd2ece6c5b798560c0c0861
https://doi.org/10.5045/br.2019.54.1.1
https://doi.org/10.5045/br.2019.54.1.1
Autor:
Francisco Galeano-Valle, Sandra Piqueras-Ruiz, Pablo Demelo-Rodríguez, Luis Álvarez-Sala-Walther, Jorge del Toro-Cervera, Irene García-Fernández-Bravo
Publikováno v:
Medicine
The clinical profile, evolution and complications of treatment with rivaroxaban in a cohort of patients presenting with venous thromboembolism (VTE) were analyzed in an observational, non-interventional and prospective study. A total of 111 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71322d6a488adafd99f9eb078ad4681e
https://doi.org/10.1097/md.0000000000014093
https://doi.org/10.1097/md.0000000000014093